Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Bococizumab in Japanese Subjects with Hypercholesterolemia
NCT02055976Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2014
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bococizumab in hypercholesterolemia, sponsored by Pfizer. Started Mar 2014; status: completed.
02
Drugs
bococizumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02055976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02055976.